KPV – 10 mg

1. Draw 2cc Bacteriostatic Water USP from vile.
2. Inject the Bacteriostatic Water into the KPV – 10 mg vial.
3. Gently swirl the vial around until the solution is completely clear. (Note: Do NOT shake – Cagrilintide is a delicate peptide and can lose potency if agitated.)
4. Once completed this will provide you with a concentration of 10mg per/2cc & 0.5mg per 10 units on the insulin needle. Note: 100 units would equate to 5mg & 200 units would equate the total 10 mg.
5. The most common injection site for administering KPV  is your lower abdomen. It’s an easy site to inject, because there’s usually more subcutaneous fat in this area. Stick to the semi-circle area below your belly button and above your pubic region. Be sure to stay at least one inch away from your belly button.
6. Storage: Once KPV – 10 mg is reconstituted, it must be refrigerated and used within 20-30 days.

KPV is commonly grouped with peptides that support immune regulation, gut health, tissue repair, skin health, and healthy inflammatory responses in research and wellness-focused protocols.

For digestive health and intestinal research, KPV is frequently paired with BPC-157, combining complementary pathways involved in gut integrity, tissue repair, and healthy inflammatory balance.

To support soft tissue recovery and regenerative research, KPV is often referenced alongside TB-500 or GHK-Cu, peptides commonly studied for their roles in connective tissue repair, skin health, and cellular regeneration.

For immune and longevity-focused protocols, KPV may also be stacked with Thymosin Alpha-1, NAD+, or MOTS-c to investigate complementary pathways involved in immune regulation, cellular resilience, and overall metabolic wellness.

KPV is an investigational peptide with limited human clinical data. Individual responses may vary depending on dosage and research protocol. As with many injectable peptides, mild injection-site irritation or temporary discomfort may occur. KPV is a non-hormonal peptide, does not exhibit anabolic or androgenic activity, and does not require post-cycle therapy.